Taiwan FDA registration 74b982a7d3e5031cbc71e69fbee4550d

Bundis Mini Naff Human Immunoglobulin G3 Set

TW: 邦迪斯迷你那夫人類免疫球蛋白 G3 套組

Taiwan·Risk Class 2·THE BINDING SITE GROUP LIMITED·Registered May 07, 2008 – May 07, 2023Expired

Registration details

Analysis ID: 74b982a7d3e5031cbc71e69fbee4550d
Customs Code: DHA00601902807

Company information

Manufacturer: THE BINDING SITE GROUP LIMITED
Manufacturer Country: United Kingdom
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: The kit provides in vitro detection of immunoglobulin IgG subtype: IgG3 in human serum, which can assist in the clinical diagnosis of abnormal metabolism of IgG3 in the human body, and the set is suitable for MININEPH TM turbidity meter as an experimental operation platform.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5510 免疫球蛋白A,G,M,D及E免疫試驗系統
Import Information: import

Dates and status

Registration Date: May 07, 2008
Expiry Date: May 07, 2023

About this record

Access comprehensive regulatory information for Bundis Mini Naff Human Immunoglobulin G3 Set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 74b982a7d3e5031cbc71e69fbee4550d and manufactured by THE BINDING SITE GROUP LIMITED. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.